Matthew W. Towse, SVP and Chief Financial Office at NxStage Medical, Inc. (NXTM), sold 4,300 shares at $23.29 ($100K) on 2017-06-20, disclosed to the SEC on 2017-06-21.
Open-market sale of $100k NXTM by SVP and Chief Financial Office. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NXTM | SELL | 2017-08-23 | $126K | — | Filing → |
| NXTM | SELL | 2017-07-21 | $104K | — | Filing → |
| NXTM | SELL | 2017-05-23 | $92K | — | Filing → |